Theravance Biopharma, Inc. (TBPH)
17.68
+0.06
(+0.37%)
USD |
NASDAQ |
Dec 11, 16:00
17.68
0.00 (0.00%)
After-Hours: 18:15
Theravance Biopharma Free Cash Flow: 243.48M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Perspective Therapeutics, Inc. | -106.85M |
| Skye Bioscience, Inc. | -41.53M |
| FibroGen, Inc. | -17.14M |
| Myomo, Inc. | -13.85M |
| VYNE Therapeutics, Inc. | -38.48M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.508M |
| Cash from Investing (Quarterly) | -100.25M |
| Cash from Financing (Quarterly) | -0.40M |
| Free Cash Flow Per Share (Quarterly) | -0.1254 |
| Free Cash Flow to Equity (Quarterly) | -4.646M |
| Free Cash Flow to Firm (Quarterly) | -7.225M |
| Free Cash Flow Yield | 27.33% |